• Piri Keşif Aracı

Arama ipuçları nelerdir?
1.  sayfa ve
1
COVID-19 in hypertensive people
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Medisan
Yazar(lar) :
María Eugenia García Céspedes , Josefa Bell Castillo , Diana Enilda Romero Calzado , Niola Ferrales Biset
Yıl :
2020
COVID-19 in hypertensive people COVID- 19 is an infectious disease caused by the SARS-CoV-2 coronavirus that affects people in advanced ages of life, patients with immunodepression and With this work we wanted to update the knowledge on the COVID- 19 serious condition level in hypertensive patients and its association with the consumption covid-19
Yayıncı Web Sitesi
Kaydet Alıntıla
COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus that affects people in advanced ages of life, patients with immunodepression and/or chronic affections, as hypertension, in a more serious way, being the latter of great significance in the mortality due to cardiovascular and cerebrovascular diseases. With this work we wanted to update the knowledge on the COVID-19 serious condition level in hypertensive patients and its association with the consumption of antihypertensive drugs of the angiotensin converting enzyme inhibitors and antagonists of angiotensin II receptors groups. In the same way, scientific evidences are offered on the fact that hypertension is a clinical predictor of a serious condition in patients with this infectious disease, that is manifested mainly in people older than 60 years, and that the suspension in a preventive way of the mentioned antihypertensive treatments can lead to clinical instability and unfavorable results.
Anahtar Kelimeler : covid-19, coronavirus sarsu2013cov-2, hipertensión arterial, tratamiento antihipertensivo.
ISSN: 1029-3019
Cilt: 24
Sayı: 3
Sayfa: 501 - 514
Sınıflandırma :
2
COVID-19, hypertension, and cardiovascular disease
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Diabetology
Yazar(lar) :
HK Chopra , R R Kasliwal , A Muruganathan , Mohsin Wali , C Venkata S Ram
Yıl :
2020
COVID-19, hypertension, and cardiovascular disease for the cardiovascular (CV) health of patients, although the respiratory disease is the predominant clinical sign of COVID- 19. Numerous patients with COVID- 19 have basic CV ailments or develop severe heart injury due to the disease. Most of the current reports on COVID- 19 have only briefly described CV manifestations in these patients. coronavirus disease-2019 (covid-19)
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular (CV) health of patients, although the respiratory disease is the predominant clinical sign of COVID-19. The presence of comorbidities such as hypertension, diabetes, and CV disease (CVD) increases the risk of morbidity and mortality due to CVD. Numerous patients with COVID-19 have basic CV ailments or develop severe heart injury due to the disease. Severe CV injury characterized by a huge rise of heart troponins is the most commonly seen effect on the heart. This happens in approximately 8%–12% of all patients. Direct myocardial injury because of viral association of cardiomyocytes and the effect of systemic inflammation appear to be the most common mechanisms responsible for the cardiac injury. The presence of preexisting CV disease and/or development of acute cardiac injury is associated with significantly worse outcomes in patients with COVID-19. Most of the current reports on COVID-19 have only briefly described CV manifestations in these patients. Given the significant adverse prognostic impact of cardiac involvement, further studies are needed on the incidence, mechanisms, clinical presentation, and outcomes of various CV manifestations in patients with COVID-19.
DOI : 10.4103/JOD.JOD_30_20
Anahtar Kelimeler : cardiovascular disease, coronavirus disease-2019 (covid-19), hypertension, type 2 diabetes
ISSN: 2078-7685
Cilt: 11
Sayı: 2
Sayfa: 57 - 64
Sınıflandırma :
3
A proposal for staging COVID‐19 coagulopathy
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Research and Practice in Thrombosis and Haemostasis
Yazar(lar) :
Jecko Thachil , Mary Cushman , Alok Srivastava
Yıl :
2020
A proposal for staging COVID‐19 coagulopathy Abstract Coronavirus disease 2019 ( COVID‐ 19) is associated with significant hypercoagulability. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID‐ 19 coagulopathy based on available COVID‐19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract Coronavirus disease 2019 (COVID‐19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID‐19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.
DOI : 10.1002/rth2.12372
Anahtar Kelimeler : anticoagulation, COVIDu201019, thrombosis
ISSN: 2475-0379
Cilt: 4
Sayı: 5
Sayfa: 731 - 736
Sınıflandırma :
4
COVID-19 Related Coagulopathy: A Distinct Entity?
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak 1:
Directory of Open Access Journals (DOAJ)
Kaynak 2:
MDPI
Dergi:
Journal of Clinical Medicine
Yazar(lar) :
Benjamin Marchandot , Laurent Sattler , Laurence Jesel , Kensuke Matsushita , Valerie Schini-Kerth , Lelia Grunebaum , Olivier Morel
Yıl :
2020
COVID-19 Related Coagulopathy: A Distinct Entity? The coronavirus disease 2019 ( COVID- 19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID- 19-related coagulopathy have shown a disproportionately worse outcome. - 19 coagulopathy. COVID-19
Piri Tam Metin Bulucu
Kaydet Alıntıla
The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.
DOI : 10.3390/jcm9061651
Anahtar Kelimeler : coronavirus disease 2019, COVID-19, thrombosis, hemostasis, microparticles, endothelium
ISSN: 2077-0383
Cilt: 9
Sayı: 1651
Sayfa: 1651
Sınıflandırma :
5
Potential role of statins in COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Infectious Diseases
Yazar(lar) :
Ken Cheah Hooi Lee , Duu Wen Sewa , Ghee Chee Phua
Yıl :
2020
Potential role of statins in COVID-19 Patients with COVID- 19 infection have an increased risk of cardiovascular complications and thrombotic events. They may have a potential role as adjunctive therapy to mitigate endothelial dysfunction and dysregulated inflammation in patients with COVID- 19 infection
Yayıncı Web Sitesi
Kaydet Alıntıla
Patients with COVID-19 infection have an increased risk of cardiovascular complications and thrombotic events. Statins are known for their pleiotropic anti-inflammatory, antithrombotic and immunomodulatory effects. They may have a potential role as adjunctive therapy to mitigate endothelial dysfunction and dysregulated inflammation in patients with COVID-19 infection.
Cilt: 96
Sayfa: 615 - 617
Sınıflandırma :
6
Statin Treatment of COVID-19
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
The American Journal of Cardiology
Yayıncı:
Elsevier
Yazar(lar) :
David S. Fedson
Yıl :
2020
Statin Treatment of COVID-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
DOI : 10.1016/j.amjcard.2020.09.050
ISSN: 0002-9149

Sınıflandırma :
7
Arterial thrombotic complications in COVID-19 patients
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Vascular Surgery Cases and Innovative Techniques
Yazar(lar) :
Stef Levolger , PhD , Reinoud P.H. Bokkers , PhD , Jan Wille , PhD , Rogier H.J. Kropman , PhD , Jean-Paul P.M. de Vries , PhD
Yıl :
2020
Arterial thrombotic complications in COVID-19 patients The coronavirus disease 2019 ( COVID- 19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been COVID- 19. Our findings demonstrate that physicians should be vigilant for signs of thrombotic complications in both hospitalized and new COVID- 19 patients. COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
The coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been described to predispose to thrombotic disease in both the venous and arterial circulations. We report four cases of an acute arterial occlusion in COVID-19 patients and literature review on the occurrence of arterial thrombosis in patients with COVID-19. Our findings demonstrate that physicians should be vigilant for signs of thrombotic complications in both hospitalized and new COVID-19 patients.
Anahtar Kelimeler : Arterial occlusion, Thrombosis, Ischemia, COVID-19, SARS-CoV-2
ISSN: 2468-4287
Cilt: 6
Sayı: 3
Sayfa: 454 - 459
Sınıflandırma :
8
COVID-19 – A vascular disease
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
Trends in Cardiovascular Medicine
Yayıncı:
Elsevier
Yazar(lar) :
Hasan K. Siddiqi , Peter Libby , Paul M Ridker
Yıl :
2020
COVID-19 – A vascular disease
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects.
DOI : 10.1016/j.tcm.2020.10.005
Anahtar Kelimeler : Endothelium, Coagulation, Thrombosis, Inflammation, Microvessels
ISSN: 1050-1738

Sınıflandırma :
9
COVID-19 and cardiovascular diseases
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
Journal of Cardiology
Yayıncı:
Elsevier
Yazar(lar) :
Francesca Mai , Rita Del Pinto , Claudio Ferri
Yıl :
2020
COVID-19 and cardiovascular diseases As of mid-June 2020, more than 4,40,000 fatal cases of SARS-CoV-2-related disease ( COVID- 19) have occurred worldwide. Besides its prominent expression at the level of the respiratory apparatus, COVID- 19 is also characterized by a substantial degree of cardiovascular involvement Herein, we summarize the main COVID- 19 features of relevance for the clinicians in the cardiovascular field. COVID-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Infection by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for the second pandemic of the XXI century after influenza A in 2009. As of mid-June 2020, more than 4,40,000 fatal cases of SARS-CoV-2-related disease (COVID-19) have occurred worldwide. Besides its prominent expression at the level of the respiratory apparatus, COVID-19 is also characterized by a substantial degree of cardiovascular involvement, both in terms of deterioration of pre-existing conditions, and as the effect of inflammation-facilitated acute events. They include ischemic/inflammatory heart disease, ventricular arrhythmias, conduction disturbances, thrombotic events at the level of the lungs, and systemic activation of the coagulation cascade, configuring the scenario of disseminated intravascular coagulation. Herein, we summarize the main COVID-19 features of relevance for the clinicians in the cardiovascular field. The rationale, concerns, and possible side effects of specific therapeutic measures, including anticoagulants, renin-angiotensin-aldosterone system inhibitors, and anti-inflammatory/antiviral medications applied to the treatment of COVID-19 are also discussed.
DOI : 10.1016/j.jjcc.2020.07.013
Anahtar Kelimeler : COVID-19, Cardiovascular diseases, Renin-angiotensin-aldosterone system inhibitors, Coagulation, Electrocardiography
ISSN: 0914-5087
Sayı: 5
Cilt: 76
Sayfa: 453-458
Sınıflandırma :
10
The renin angiotensin aldosterone system and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Saudi Pharmaceutical Journal
Yazar(lar) :
Hadeel A. Alsufyani , James R. Docherty
Yıl :
2020
The renin angiotensin aldosterone system and COVID-19 The ongoing pandemic has stimulated study of the Renin Angiotensin Aldosterone System (RAAS), and how it can be manipulated to treat COVID- 19. Studies are examining whether drugs that act on the RAAS system might be useful to treat COVID- 19. COVID- 19 and the RAAS are closely linked both in infection and in possible post-infection inflammatory cascades. COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
The ongoing pandemic has stimulated study of the Renin Angiotensin Aldosterone System (RAAS), and how it can be manipulated to treat COVID-19. Studies are examining whether drugs that act on the RAAS system might be useful to treat COVID-19. COVID-19 and the RAAS are closely linked both in infection and in possible post-infection inflammatory cascades. We detail the Physiology and Pharmacology of the RAAS including the effects of aldosterone and atrial natriuretic peptide. It is appropriate that the theoretical benefits of modulation of the RAAS should be considered based on available knowledge of the complexity of the system. In this short review we have tried to explain the actions of the angiotensin family of peptides and produce a relatively simple model and diagrammatic summary of the RAAS and the possible sites of intervention.
Anahtar Kelimeler : Angiotensin, COVID-19
ISSN: 1319-0164
Cilt: 28
Sayı: 8
Sayfa: 977 - 984
Sınıflandırma :
11
Thrombosis Risk Assessment In The COVID-19 Era
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Revista Ciências em Saúde
Yazar(lar) :
Joseph A Caprini
Yıl :
2020
Thrombosis Risk Assessment In The COVID-19 Era covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The appearance of the coronavirus pandemic has prompted a renewed interest in thrombosis risk assessment, particularly since this disease is associated with a high risk of thrombotic events. It is known that the number one preventable cause of death in hospitalized patients including those having surgical procedures is fatal pulmonary emboli. There is also high-quality data that the use of anticoagulant drugs in the proper dose, and for the period of time shown to be efficacious, will prevent most fatal events. It is true that even with the use of the best anticoagulant regimes venous thromboembolic events (VTE) can still occur but are rarely fatal. We also realize that providing adequate anticoagulant prophylaxis for the entire period of risk is the key to preventing these deaths. Thrombosis risk scoring identifies who's at risk for these emboli and guides physician choices for appropriate preventive measures.
DOI : 10.21876/rcshci.v10i3.1006
Anahtar Kelimeler : covid-19, tromboembolism, risk assessment
ISSN: 2236-3785
Cilt: 10
Sayı: 3
Sayfa: 1 - 2
Sınıflandırma :
12
ST Elevations in the Era of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak 1:
Directory of Open Access Journals (DOAJ)
Kaynak 2:
Hindawi Limited
Dergi:
Case Reports in Cardiology
Yazar(lar) :
Charlie Joseph Sang , Brittain Heindl , Gregory Von Mering , Brigitta Brott , Robert S. Kopf , Indranee Rajapreyar
Yıl :
2020
ST Elevations in the Era of COVID-19 Coronavirus disease 2019 ( COVID- 19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID- 19 and review important diagnostic and management
Piri Tam Metin Bulucu
Kaydet Alıntıla
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for the front-line clinician.
DOI : 10.1155/2020/8845627
Cilt: 2020
Sınıflandırma :
13
COVID-19 infection and cardiac arrhythmias
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
Trends in Cardiovascular Medicine
Yayıncı:
Elsevier
Yazar(lar) :
Antonis S. Manolis , Antonis A. Manolis , Theodora A. Manolis , Evdoxia J. Apostolopoulos , Despoina Papatheou , Helen Melita
Yıl :
2020
COVID-19 infection and cardiac arrhythmias As the coronavirus 2019 ( COVID- 19) pandemic marches unrelentingly, more patients with cardiac arrhythmias are emerging due to the effects of the virus on the respiratory and cardiovascular (CV) systems and the systemic inflammation that it incurs, and also as a result of the proarrhythmic effects of COVID - 19 pharmacotherapies and other drug interactions and the associated autonomic imbalance that enhance arrhythmogenicity. COVID-19 COVID-19 coronavirus 2019
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
As the coronavirus 2019 (COVID-19) pandemic marches unrelentingly, more patients with cardiac arrhythmias are emerging due to the effects of the virus on the respiratory and cardiovascular (CV) systems and the systemic inflammation that it incurs, and also as a result of the proarrhythmic effects of COVID-19 pharmacotherapies and other drug interactions and the associated autonomic imbalance that enhance arrhythmogenicity. The most worrisome of all arrhythmogenic mechanisms is the QT prolonging effect of various anti-COVID pharmacotherapies that can lead to polymorphic ventricular tachycardia in the form of torsade des pointes and sudden cardiac death. It is therefore imperative to monitor the QT interval during treatment; however, conventional approaches to such monitoring increase the transmission risk for the staff and strain the health system. Hence, there is dire need for contactless monitoring and telemetry for inpatients, especially those admitted to the intensive care unit, as well as for outpatients needing continued management. In this context, recent technological advances have ushered in a new era in implementing digital health monitoring tools that circumvent these obstacles. All these issues are herein discussed and a large body of recent relevant data are reviewed.
DOI : 10.1016/j.tcm.2020.08.002
Anahtar Kelimeler : COVID-19, SARS-CoV-2, Myocarditis, Cardiac arrhythmias, Atrial fibrillation, Sudden cardiac death, Long QT syndrome, Torsade des pointes, Ventricular tachycardia, Ventricular fibrillation, AAD antiarrhythmic drug, antiarrhythmic drug, AF atrial fibrillation, atrial fibrillation, APCs atrial premature complexes, atrial premature complexes, AZM azithromycin, azithromycin, COVID-19 coronavirus 2019, coronavirus 2019, CQ chloroquine, chloroquine, cTn cardiac troponin, cardiac troponin, CV cardiovascular, cardiovascular, CYP cytochrome P450, cytochrome P450, ECG electrocardiogram, electrocardiogram, HCQ hydroxychloroquine, hydroxychloroquine, ICU intensive care unit, intensive care unit, LQTS long QT syndrome, long QT syndrome, NSVT non-sustained ventricular tachycardia, non-sustained ventricular tachycardia, OOHCA out-of-hospital cardiac arrest, out-of-hospital cardiac arrest, SCD sudden cardiac death, sudden cardiac death, TdP torsade des pointes, torsade des pointes, VAs ventricular arrhythmias, ventricular arrhythmias, VF ventricular fibrillation, ventricular fibrillation, VPCs ventricular premature complexes, ventricular premature complexes, VT ventricular tachycardia, ventricular tachycardia
ISSN: 1050-1738

Sınıflandırma :
14
Extensive Arterial Thrombosis in Covid-19
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
The American Journal of Cardiology
Yayıncı:
Elsevier
Yazar(lar) :
Lauren E. Merz , Lauren Sinnenberg , Marie D. Gerhard-Herman , Muthiah Vaduganathan
Yıl :
2020
Extensive Arterial Thrombosis in Covid-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
DOI : 10.1016/j.amjcard.2020.07.056
ISSN: 0002-9149
Cilt: 134
Sayfa: 148-149
Sınıflandırma :
15
Interventional Stroke Care in the Era of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Neurology
Yazar(lar) :
Hisham Salahuddin , Alicia C. Castonguay , Syed F. Zaidi , Syed F. Zaidi , Richard Burgess , Ashutosh P. Jadhav , Mouhammad A. Jumaa , Mouhammad A. Jumaa
Yıl :
2020
Interventional Stroke Care in the Era of COVID-19 Patients with severe symptoms of COVID- 19 may also present with acute neurological emergencies such as ischemic stroke. , or concurrent ischemic stroke from common stroke risk factors in a patient with COVID- 19. Lastly, we describe an illustrative case of a patient with ischemic stroke and COVID- 19. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The current coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to immense strain on healthcare systems and workers. Patients with severe symptoms of COVID-19 may also present with acute neurological emergencies such as ischemic stroke. Ischemic stroke in these patients may result from COVID-19 related complications or decompensation of previously asymptomatic cerebrovascular disorders, or concurrent ischemic stroke from common stroke risk factors in a patient with COVID-19. Acute ischemic stroke patients with large vessel occlusions require emergent triage, intensive care, and mechanical thrombectomy. Management of patients with large vessel occlusions (LVO) requires special considerations in the current pandemic. Physicians must now account for prognosis of severe COVID-19, resource utilization, and risk of infection to healthcare workers when determining eligibility for mechanical thrombectomy (MT). Here, we describe important prognostic factors including age, laboratory, and imaging findings to consider for MT selection and provide suggestions for taking care of patients with LVO and possible or confirmed COVID-19. It is recommended to perform MT in patients within the established guidelines, and consider a conservative approach in cases where there is clinical equipoise to minimize futile reperfusion. Lastly, we describe an illustrative case of a patient with ischemic stroke and COVID-19.
DOI : 10.3389/fneur.2020.00468
Anahtar Kelimeler : COVID-19, stroke, pandemic, thrombectomy, ischemic, coronavirus
ISSN: 1664-2295
Cilt: 11
Sınıflandırma :
16
Coronary thrombosis in a young male with COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
IDCases
Yazar(lar) :
Abdullah Shams , Fateen Ata , Kamran Mushtaq , Waqar Munir , Zohaib Yousaf
Yıl :
2020
Coronary thrombosis in a young male with COVID-19 COVID- 19 predominantly presents with respiratory symptoms, but other presentations are reported, including cardiac manifestations and thromboembolism. We present a healthy young gentleman with COVID- 19 pneumonia, who developed acute ST-segment elevation myocardial infarction (STEMI) due to coronary thrombosis COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
COVID-19 predominantly presents with respiratory symptoms, but other presentations are reported, including cardiac manifestations and thromboembolism. We present a healthy young gentleman with COVID-19 pneumonia, who developed acute ST-segment elevation myocardial infarction (STEMI) due to coronary thrombosis. He was managed successfully by primary percutaneous coronary intervention (PPCI).
Anahtar Kelimeler : COVID-19, Myocardial infarction, Thrombosis, SARS-CoV-2
ISSN: 2214-2509
Cilt: 21
Sayfa: e00923
Sınıflandırma :
17
COVID‐19 research: an opinion piece
Dergi Makalesi

Dergi Makalesi
Kaynak :
Wiley Online Library
Dergi:
HIV Medicine
Yazar(lar) :
L Waters , JK Rockstroh
Konu :
Health Policy, Pharmacology (medical), Infectious Diseases
Yıl :
2020
COVID‐19 research: an opinion piece The unprecedented global scale of COVID‐ 19 globally has triggered a race to discover interventions to reduce associated morbidity and mortality and rapid Here we summarize the evidence for antiretrovirals to treat COVID‐ 19 and, as a drug that has also been studied in HIV, hydroxychloroquine, and flag some
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
The unprecedented global scale of COVID‐19 globally has triggered a race to discover interventions to reduce associated morbidity and mortality and rapid release of research findings prior to any degree of critical review. As with previous novel infection outbreaks, antiretrovirals are just one drug class that has been held up as a potential strategy for prophylaxis and treatment with scant evidence and risk of harm. Here we summarize the evidence for antiretrovirals to treat COVID‐19 and, as a drug that has also been studied in HIV, hydroxychloroquine, and flag some of the pitfalls of using therapies that have not been evaluated robustly.
DOI : 10.1111/hiv.12913
ISSN: 1464-2662
Sayı: 8
Cilt: 21
Sayfa: 536-540
Sınıflandırma :
18
Multisystemic Infarctions in COVID-19: Focus on the Spleen
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
European Journal of Case Reports in Internal Medicine
Yazar(lar) :
Mariana Santos Leite Pessoa , Carla Franco Costa Lima , Ana Carla Farias Pimentel , José Carlos Godeiro Costa Júnior , Jorge Luis Bezerra Holanda
Yıl :
2020
Multisystemic Infarctions in COVID-19: Focus on the Spleen The literature suggests that COVID- 19 provokes arterial and venous thrombotic events, although the mechanism is still unknown. More data are required to elucidate how COVID- 19 and thrombotic disease interact and so that preventive and early diagnosis strategies can be developed covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The literature suggests that COVID-19 provokes arterial and venous thrombotic events, although the mechanism is still unknown. In this study, we describe patients with confirmed coronavirus infection associated with multisystemic infarction, focusing on splenic infarction. More data are required to elucidate how COVID-19 and thrombotic disease interact and so that preventive and early diagnosis strategies can be developed.
DOI : 10.12890/2020_001747
Anahtar Kelimeler : sars-cov-2, covid-19, pneumonia, coronavirus, disseminated intravascular coagulation, splenic infarction
ISSN: 2284-2594
Sınıflandırma :
19
Social reaction toward the 2019 novel coronavirus (COVID-19)
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Social Health and Behavior
Yazar(lar) :
Chung-Ying Lin
Yıl :
2020
Social reaction toward the 2019 novel coronavirus (COVID-19)
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.4103/SHB.SHB_11_20
ISSN: 2589-9767
Cilt: 3
Sayı: 1
Sayfa: 1 - 2
Sınıflandırma :
20
Current data on the cardiovascular effects of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Hellenic Journal of Cardiology
Yazar(lar) :
Panayotis K. Vlachakis , Anastasios Tentolouris , Dimitris Tousoulis , Nikolaos Tentolouris
Yıl :
2020
Current data on the cardiovascular effects of COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
ISSN: 1109-9666
Cilt: 61
Sayı: 1
Sayfa: 46 - 48
Sınıflandırma :
21
Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Clinical Medicine
Yazar(lar) :
Marco Schiavone , Cecilia Gobbi , Giuseppe Biondi-Zoccai , Fabrizio Du2019Ascenzo , Alberto Palazzuoli , Alessio Gasperetti , Gianfranco Mitacchione , Maurizio Viecca , Massimo Galli , Francesco Fedele , Massimo Mancone , Giovanni Battista Forleo
Yıl :
2020
Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties - 19) pandemic. This review aims to discuss the pathophysiological links between MI, respiratory infections, and Covid- 19; epidemiological data related to ACS at the time of the Covid- 19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order Covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Since an association between myocardial infarction (MI) and respiratory infections has been described for influenza viruses and other respiratory viral agents, understanding possible physiopathological links between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS) is of the greatest importance. The initial data suggest an underestimation of ACS cases all over the world, but acute MI still represents a major cause of morbidity and mortality worldwide and should not be overshadowed during the coronavirus disease (Covid-19) pandemic. No common consensus regarding the most adequate healthcare management policy for ACS is currently available. Indeed, important differences have been reported between the measures employed to treat ACS in China during the first disease outbreak and what currently represents clinical practice across Europe and the USA. This review aims to discuss the pathophysiological links between MI, respiratory infections, and Covid-19; epidemiological data related to ACS at the time of the Covid-19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order to shed some light on the current strategies for optimal management of ACS patients with confirmed or suspected SARS-CoV-2 infection.
DOI : 10.3390/jcm9061683
Anahtar Kelimeler : acute coronary syndromes, myocardial infarction, STEMI, Covid-19, infectious disease, respiratory infections
ISSN: 2077-0383
Cilt: 9
Sayı: 1683
Sayfa: 1683
Sınıflandırma :
22
Anticoagulation practice patterns in COVID‐19: A global survey
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Research and Practice in Thrombosis and Haemostasis
Yazar(lar) :
Rachel P. Rosovsky , Kristen M. Sanfilippo , Tzu Fei Wang , Sandeep K. Rajan , Surbhi Shah , Karlyn A. Martin , Fionnuala Ní Áinle , Menno Huisman , Beverley J. Hunt , Susan R. Kahn , Barry Kevane , Agnes Y. Y. Lee , Claire McLintock , Lisa Baumann Kreuziger
Yıl :
2020
Anticoagulation practice patterns in COVID‐19: A global survey Objectives We aimed to assess current global practice and experience in management of COVID‐ 19–associated coagulopathy to identify information to guide Methods Physicians were queried about their current approach to prophylaxis, diagnosis, and treatment of VTE in patients with COVID‐ 19 using an online ‐ 19. COVID‐19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract Background Best practice for prevention, diagnosis, and management of venous thromboembolism (VTE) in patients with coronavirus disease 2019 (COVID‐19) is unknown due to limited published data in this population. Objectives We aimed to assess current global practice and experience in management of COVID‐19–associated coagulopathy to identify information to guide prospective and randomized studies. Methods Physicians were queried about their current approach to prophylaxis, diagnosis, and treatment of VTE in patients with COVID‐19 using an online survey tool distributed through multiple international organizations between April 10 and 14, 2020. Results Five hundred fifteen physicians from 41 countries responded. The majority of respondents (78%) recommended prophylactic anticoagulation for all hospitalized patients with COVID‐19, with most recommending use of low‐molecular‐weight heparin or unfractionated heparin. Significant practice variation was found regarding the need for dose escalation of anticoagulation outside the setting of confirmed or suspected VTE. Respondents reported the use of bedside testing when unable to perform standard diagnostic imaging for diagnosis of VTE. Two hundred ninety‐one respondents reported observing thrombotic complications in their patients, with 64% noting that the complication was pulmonary embolism. Of the 44% of respondents who estimated incidence of thrombosis in patients with COVID‐19 in their hospital, estimates ranged widely from 1% to 50%. One hundred seventy‐four respondents noted bleeding complications (34% minor bleeding, 14% clinically relevant nonmajor bleeding, and 12% major bleeding). Conclusion Well‐designed epidemiologic studies are urgently needed to understand the incidence and risk factors of VTE and bleeding complications in patients with COVID‐19. Randomized clinical trials addressing use of anticoagulation are also needed.
DOI : 10.1002/rth2.12414
Anahtar Kelimeler : anticoagulants, bleeding, blood coagulation, COVIDu201019, venous thromboembolism
ISSN: 2475-0379
Cilt: 4
Sayı: 6
Sayfa: 969 - 983
Sınıflandırma :
23
Post COVID-19 Acute Myocardial Infarction Rebound
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
Canadian Journal of Cardiology
Yayıncı:
Elsevier
Yazar(lar) :
Alexander Fardman , Daniel Oren , Anat Berkovitch , Amit Segev , Yuval Levy , Roy Beigel , Shlomi Matetzky
Yıl :
2020
Post COVID-19 Acute Myocardial Infarction Rebound
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
DOI : 10.1016/j.cjca.2020.08.016
ISSN: 0828-282X

Sınıflandırma :
24
Cardiovascular disease in the context of the COVID-19 pandemic
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Noncommunicable Diseases
Yazar(lar) :
Shanthi Mendis
Yıl :
2020
Cardiovascular disease in the context of the COVID-19 pandemic Emerging evidence indicate a close relationship between coronavirus disease 2019 ( COVID- 19) and cardiovascular diseases (CVDs). As outlined in this review, cardiovascular manifestations of COVID- 19 are complex with patients presenting with one or more of the following: myocarditis - 19 burden. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Emerging evidence indicate a close relationship between coronavirus disease 2019 (COVID-19) and cardiovascular diseases (CVDs). Age is a potent shared risk factor which links the two conditions. Although severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) principally affects the lungs, a sizeable number of patients develop new-onset cardiac dysfunction during the course of the illness. As outlined in this review, cardiovascular manifestations of COVID-19 are complex with patients presenting with one or more of the following: myocarditis, acute myocardial infarction, stroke, cardiomyopathy, heart failure, arrhythmias, acute pericarditis, and venous thromboembolism. Preexisting CVDs make people more vulnerable to SARS-CoV-2 infection and adversely impact clinical outcomes. The World Cardiology Associations have issued consensus-based guidance to ensure that cardiac and stroke care needs of people, are met effectively within the context of the COVID-19 burden. Clinicians caring for COVID-19 patients need to be aware of the potential cardiovascular side effects of various therapies used for treating SARS-CoV-2 infection, including chloroquine/hydroxychloroquine and azithromycin. Research is essential to better understand the mechanisms that shape the close interplay between SARS-CoV-2 infection and CVDs.
DOI : 10.4103/jncd.jncd_31_20
Anahtar Kelimeler : cardiomyopathy, cardiovascular disease, covid-19, myocardial infarction, myocarditis, pandemic, stroke
Cilt: 5
Sayı: 2
Sayfa: 50 - 57
Sınıflandırma :
25
Possible Mechanism and Current Recommendation of Thromboembolism in COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Open Access Macedonian Journal of Medical Sciences
Yazar(lar) :
Dita Aulia Rachmi , Eka Prasetya Budi Mulia , Johanes Nugroho
Yıl :
2020
Possible Mechanism and Current Recommendation of Thromboembolism in COVID-19 The coronavirus disease ( COVID- 19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID- 19 infection. Prophylaxis anticoagulant was proposed for all hospitalized COVID- 19 patients. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.
DOI : 10.3889/oamjms.2020.4900
Anahtar Kelimeler : COVID-19, venous thromboembolism, thrombosis, anticoagulation
ISSN: 1857-9655
Cilt: 8
Sayı: T1
Sınıflandırma :
26
COVID-19 in patients with cardiovascular diseases
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
Archives of Cardiovascular Diseases
Yayıncı:
Elsevier
Yazar(lar) :
Jean-Sébastien Hulot
Yıl :
2020
COVID-19 in patients with cardiovascular diseases COVID-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
DOI : 10.1016/j.acvd.2020.03.009
Anahtar Kelimeler : COVID-19, Acute cardiac injury, Hypertension, Heart failure, Myocardium, COVID19, Cardiopathie, Hypertension, Risque cardiovasculaire
ISSN: 1875-2136
Sayı: 4
Cilt: 113
Sayfa: 225-226
Sınıflandırma :
27
Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Vascular Biology
Yazar(lar) :
Paolo Madeddu
Yıl :
2020
Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : https://doi.org/10.1530/VB-20-0008
ISSN: 2516-5658
Cilt: 2
Sayı: 1
Sayfa: E3 - E6
Sınıflandırma :
28
Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
Dergi Makalesi

Dergi Makalesi
Kaynak :
Science Direct
Dergi:
Thrombosis Research
Yayıncı:
Elsevier
Yazar(lar) :
D.J. Hoechter , A. Becker-Pennrich , J. Langrehr , M. Bruegel , B. Zwissler , S. Schaefer , M. Spannagl , L.C. Hinske , M. Zoller
Yıl :
2020
Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients Background COVID- 19 is a novel viral disease. Severe courses may present as ARDS. INR (p < 0.001) and antithrombin (p < 0.001) were higher in COVID- 19 patients. In ExTEM®, Time-to-Twenty (TT20) was shorter in the COVID- 19 group (p = 0.047), these patients also had higher FibTEM® MCF (p = 0.005). COVID-19 coronavirus disease 19 coronavirus disease 19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Background COVID-19 is a novel viral disease. Severe courses may present as ARDS. Several publications report a high incidence of coagulation abnormalities in these patients. We aimed to compare coagulation and inflammation parameters in patients with ARDS due to SARS-CoV-2 infection versus patients with ARDS due to other causes. Methods This retrospective study included intubated patients admitted with the diagnosis of ARDS to the ICU at Munich university hospital. 22 patients had confirmed SARS-CoV2-infection (COVID-19 group), 14 patients had bacterial or other viral pneumonia (control group). Demographic, clinical parameters and laboratory tests including coagulation parameters and thromboelastometry were analysed. Results No differences were found in gender ratios, BMI, Horovitz quotients and haemoglobin values. The median SOFA score, serum lactate levels, renal function parameters (creatinine, urea) and all inflammation markers (IL-6, PCT, CRP) were lower in the COVID-19 group (all: p < 0.05). INR (p < 0.001) and antithrombin (p < 0.001) were higher in COVID-19 patients. D-dimer levels (p = 0.004) and consecutively the DIC score (p = 0.003) were lower in this group. In ExTEM®, Time-to-Twenty (TT20) was shorter in the COVID-19 group (p = 0.047), these patients also had higher FibTEM® MCF (p = 0.005). Further, these patients presented with elevated antigen and activity levels of von-Willebrand-Factor (VWF). Conclusion COVID-19 patients presented with higher coagulatory potential (shortened global clotting tests, increased viscoelastic and VWF parameters), while DIC scores were lower. An intensified anticoagulation regimen based on an individual risk assessment is advisable to avoid thromboembolic complications.
DOI : 10.1016/j.thromres.2020.08.030
Anahtar Kelimeler : aPTT activated partial thromboplastin time, activated partial thromboplastin time, ARDS acute respiratory distress syndrome, acute respiratory distress syndrome, BMI body mass index, body mass index, CFT clot formation time, clot formation time, COVID-19 coronavirus disease 19, coronavirus disease 19, CRP C-reactive protein, C-reactive protein, CT clotting time, clotting time, DIC disseminated intravascular coagulation, disseminated intravascular coagulation, ECMO extracorporeal membrane oxygenation, extracorporeal membrane oxygenation, FEU fibrinogen equivalent units, fibrinogen equivalent units, GGT gamma-glutamyl-transferase, gamma-glutamyl-transferase, GOT glutamate-oxaloacetate-transaminase, glutamate-oxaloacetate-transaminase, GPT glutamate-pyruvate-transaminase, glutamate-pyruvate-transaminase, ICU intensive care unit, intensive care unit, IL-6 interleukin 6, interleukin 6, INR international normalized ratio, international normalized ratio, MCF maximum clot firmness, maximum clot firmness, ML maximum lysis, maximum lysis, PCT procalcitonin, procalcitonin, SOFA sequential organ failure assessment, sequential organ failure assessment, TT20 Time-to-Twenty, Time-to-Twenty, VWF von-Willebrand-Factor, von-Willebrand-Factor, Anaesthesia and Intensive Care (4), Acute respiratory distress syndrome (ARDS) (4.01), Intensive Care (4.24), SARS-CoV-2
ISSN: 0049-3848
Cilt: 196
Sayfa: 186-192
Sınıflandırma :

Yayın Yılı

Sınırla

Doküman Türü
Tümü

Veri Tabanı
Tümü

Dergi İsmi
Tümü

Disiplin
Tümü

Disipline Göre İlgililik

Alt Disiplin
Tümü

Konu
Tümü

Yayıncı
Tümü

Lisan
Tümü

X
Filtreler